SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer

SET and MYND domain-containing protein 3 (SMYD3) is a lysine methyltransferase, and its aberrant expression has been implicated in several malignancies. However, its clinical and biological roles in non-small cell lung cancer (NSCLC) remain unclear. In the present study, it was revealed that SMYD3 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Zhao, Lifang, Pan, Yunjian, Ma, Xiao, Liu, Li, Wang, Wuzhang, You, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384847/
https://www.ncbi.nlm.nih.gov/pubmed/32705243
http://dx.doi.org/10.3892/ijo.2020.5095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384847/
https://www.ncbi.nlm.nih.gov/pubmed/32705243
http://dx.doi.org/10.3892/ijo.2020.5095

Ejemplares similares